Search Constraints
« Previous |
1 - 20 of 29
|
Next »
Search Results
Select an image to start the slideshow
Exploiting DNA-encoded library : technology for the discovery of novel antibody recruiting molecules against LOX-1
1 of 20
Approaches to lead generation for idiopathic pulmonary fibrosis targets
2 of 20
Investigations into the generation and pleiotropic reactivity modes of the nitrile imine 1,3-dipole
3 of 20
The development of small molecule inhibitors for fibrosis drug discovery
4 of 20
Expedient access to C-aryl linked saturated heterocyclic motifs
5 of 20
The development of novel organocatalytic and transition-metal catalysed methodologies for amide bond formation
6 of 20
The design and synthesis of molecular tools for probing biological function
7 of 20
New methods for the construction of selectively difluorinated carbocycles
8 of 20
Development of new synthetic approaches in solid-phase peptide synthesis
9 of 20
Synthetic approaches to heterocyclic systems of pharmaceutical relevance
10 of 20
Investigation and application of 3-Oxabicyclo[4.1.0]heptane as a mechanistic target of rapamycin (mTOR) kinase hinge binding fragment
11 of 20
Structure-guided discovery of a novel steroid-derived family of autotaxin inhibitors based on endogenous allosteric modulators
12 of 20
Development of novel allosteric regulators of proteinase-activated receptors
13 of 20
The design, synthesis and optimisation of calcium release-activated calcium (CRAC) channel inhibitors and mitochondrial permeability transition pore (mPTP) modulators, using phenotypic screening
14 of 20
Application of computer vision in industrially important reactions
15 of 20
Homogeneous hydrogenation and photochemistry as tools in pharmaceutical process development
16 of 20
The development of natural products as phytotoxic leads for herbicide discovery
17 of 20
Structure-guided approaches to the design of novel autotaxin inhibitors
18 of 20
The synthesis and optimisation of toll-like receptor agonists as potential immunomodulatory agents
19 of 20
Synthesis and evaluation of novel small molecule inhibitors of the androgen receptor amino-terminal domain for the treatment of castration-resistant prostate cancer
20 of 20